News | Cardiovascular Business | April 21, 2022

Atlantic Health System’s Morristown Medical Center Offers First in the U.S. Fellowship for Hypertrophic Cardiomyopathy (HCM) and Sports Cardiology

HCM is the most common structural heart disease in athletes with sudden cardiac arrest

Morristown Medical Center

Morristown Medical Center


April 21, 2022 – Atlantic Health System’s Morristown Medical Center (MMC) announced that it is offering the first fellowship in the United States for hypertrophic cardiomyopathy (HCM) and sports cardiology. The program will be led by Matthew Martinez, MD, FACC, Medical Director of Sports Cardiology at Atlantic Health System and Co-Director, Chanin T. Mast Center for HCM at MMC.

HCM is the most common hereditary heart disease that results in the walls of the heart becoming excessively thick causing blood flow obstruction. Symptoms often overlap other medical complaints which can delay diagnosis and complicate treatment. HCM afflicts one in 500 people worldwide yet estimates indicate only 15 percent of those patients are diagnosed, leaving 85 percent undiagnosed. HCM is the most common structural heart disease in athletes with sudden cardiac arrest. Dr. Martinez is part of many national and international efforts to increase education and care for those with HCM and athletes with risk for cardiac arrest. Specific training focused on HCM and care of athletes will continue that mission.

In the last decade there is an increased focus on care of HCM and athletes with an increased demand for cardiologists who are specially trained to assess, diagnose, and manage HCM and athletes. Over the last few years, it has become evident that the quality and consistency of HCM diagnoses vary considerably. The primary goal of the HCM and Sports Cardiology fellowship is to help improve the diagnosis and care for these patients.

“There is no better way to gain expertise in a complex problem than to fully immerse yourself in it for a year, and learn all you can about it,” said Dr. Martinez. “The first of its kind fellowship leverages the expertise we have here at Atlantic Health System from our nationally recognized cardiac surgical, interventional cardiology and advanced cardiac imaging programs that are paramount for HCM and athlete care.”

More about Dr. Martinez

Matthew MartinezDr. Martinez regularly presents on sports cardiology and HCM on the national and international stage and had previously served as the American College of Cardiology Chair of Sports and Exercise. Dr. Martinez has expertise in advanced cardiac imaging using echo, cardiac MRI and CT, and has led many educational events nationally and internationally on these topics. He has also served as the educational program chairman for the International Athletic Heart Symposium on management of athletes with cardiovascular risk. Dr. Martinez serves as a cardiology consultant for elite and professional athletes including acting as the league cardiologist for Major League Soccer, team cardiologist for the New York Jets, and cardiac consultant for the NFL.

As a national leader in the research and treatment of cardiac disease, Gagnon Cardiovascular Institute at Morristown Medical Center presently offers cardiovascular disease and interventional fellowship programs designed to train fellows to provide compassionate, patient-centered and evidence-based care in a state-of-the-art referral center.

For more information: https://www.atlantichealth.org/

 

 

Related content:

VIDEO: Study Reviews Severity of COVID-19 Heart Inflammation in College Athletes

Cardiac MRI Effective in Detecting Asymptomatic, Symptomatic Myocarditis in Athletes

Cardiac MRI Shows Lower Degrees of Myocarditis in Athletes Recovered from COVID-19

New Multimodality Cardiac Imaging Guidelines for Competitive Athletes Created

 


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now